Roots Analysis has announced the addition of “CD-47 Targeting Therapeutics Market, 2021-2035” report to its list of offerings.

In recent years, the focus of the research community has shifted towards the development of novel treatment modalities, such as T- cell immunotherapies, that exhibit high efficacy. CD-47, owing to its increased expression on the surface of cancer cells, has emerged as a cancer immune checkpoint biomarker.

To order this 190+ page report, which features…

Roots Analysis has announced the addition of “Fc Fusion Therapeutics Market, 2021-2030” report to its list of offerings.

With 13 drugs approved in the European Union and the US, Fc fusion therapeutics are considered to be one of the most successful classes of IgG-based products. The success of these biopharmaceutical products can be attributed to their diverse biological and pharmacological properties, including an extended serum half-life, enhanced Fc mediated effector functions,…

Roots Analysis has announced the addition of “Alzheimer's Disease Market (2nd Edition), 2021-2031” report to its list of offerings.

Limited treatment options and unmet needs are the key drivers of research activity in this domain. Several industry and non-industry players are presently engaged in developing various types of disease modifying interventions and drug / therapy candidates that offer symptomatic relief. Moreover, multiple venture capital firms and other strategic investors…

Roots Analysis is pleased to announce the publication of its recent study, titled, “Biologics Fill / Finish Services Market, 2019-2030.”

The report features an extensive study on the contract service providers offering drug product manufacturing services within the biopharmaceutical industry. The study features in-depth analysis, highlighting the capabilities of a diverse set of companies that claim to specialize in fill / finish operations. Amongst other elements, the report…

During our research, we were able to identify 85 industry players claim to have the required capabilities to effectively design and plan clinical trials for both therapeutic products and devices. Most of the players engaged in this domain were established pre-2001 (28%). Further, over the last decade, the clinical trial planning and design has witnessed a surge in the establishment of new players.

It is worth highlighting that most of the industry clinical trial planning and design…

During our study, we were able to identify over 200 remote patient monitoring (RPM) tools and software. It is worth mentioning, the RPM tools and software market is dominated by the presence of small companies (57%), followed by mid-sized players (23%). This can be attributed to the fact that healthcare domain has seen a shift from traditional medicines to telehealth solutions in the recent years, especially with increase in cases where the patients are not able to frequently visit their…

Several academic groups, including various universities and hospitals, are contributing significantly towards the development of these novel therapeutics against various oncological disorders. Eminent researchers and experienced scientists, affiliated to such renowned research / academic institutes, are generally chosen to lead clinical investigations for specific disease areas. Various principal investigators or sub-investigators or study directors of clinical trials, considering them to be…

Presently, more than 150 pre-sterilized / RTU primary packaging systems, including cartridges, syringes and vials, as well as their respective closure systems are available worldwide. Majority (50%) of the pre-sterilized / RTU primary packaging systems are closures, followed by containers (34%) and container-closure systems (16%). It is worth highlighting that, of the total, 54 closures are suitable for use with vials, 19 are suitable for use with syringes and the remaining 5 are compatible…

Roots Analysis is pleased to announce the publication of its recent study, titled, “Modular Facilities in Pharmaceutical and Biotechnology Market”

The report features an extensive study of the current market landscape and future potential of the players engaged in offering services for modular facility construction for biotechnology and pharmaceutical industries. The study presents an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain.…

Roots Analysis has announced the addition of “Teleradiology Services Market, 2021-2030” report to its list of offerings.

Teleradiology is a branch of telemedicine that uses telecommunication systems for the transmission of radiological images from one location to another. Such services enable hospitals / diagnostic centers to manage heavy workload, while maintaining high report quality with lower discrepancies and better reporting efficiency. Following the onset of COVID-19 pandemic,…

Roots Analysis has announced the addition of “Porphyria Targeting Therapies Market, 2021-2030” report to its list of offerings.

Porphyria is a rare disorder that is characterized by excessive accumulation of porphyrin, a compound that aids in the formation of heme (an essential part of hemoglobin that helps carry oxygen in blood). Any anomaly caused by genetic or acquired abnormalities in heme biosynthesis (produced majorly in bone marrow and liver) can result in toxicity. It is worth…

London

Roots Analysis has announced the addition of the “Cell Therapy Consumables Market, 2021 – 2031” report to its list of offerings.

Currently, more than 800 IND applications have been filed for cell therapies, while close to 10 cell-based / gene therapies are likely to receive approval in 2021 across the world. This has prompted several drug developers to rely on third-party service providers that claim to have the required skillset and technical infrastructure for the…

Roots Analysis has done a detailed study on Next Generation Sequencing Kits Market, covering key aspects of the industry’s evolution and identifying potential future growth opportunities.

To order this 200+ page report, which features 70+ figures and 120+ tables, please visit this https://www.rootsanalysis.com/reports/next-generation-sequencing-kits-market.html

Key Market Insights…

London

Roots Analysis has announced the addition of “Fc Fusion Therapeutics Market, 2021-2030” report to its list of offerings.

With 13 drugs approved in the European Union and the US, Fc fusion therapeutics are considered to be one of the most successful classes of IgG-based products. The success of these biopharmaceutical products can be attributed to their diverse biological and pharmacological properties, including an extended serum half-life, enhanced Fc mediated effector…

Roots Analysis has announced the addition of “At-Home Blood Collection and Micro Sampling Devices market, 2021-2030” report to its list of offerings.

The report features an extensive study of the current market landscape and the likely adoption of at-home self-blood collection and micro sampling devices, over the next decade. The study features a detailed analysis of the key drivers and trends related to this evolving domain. Amongst other elements, the report features:

 A…

Upon realizing the potential of this novel target, industry stakeholders have initiated several R&D efforts focused on exploiting the use of CD-47 as an effective biomarker for the diagnosis and treatment purposes

Roots Analysis is pleased to announce the publication of its recent study, titled, “CD-47 Targeting Therapeutics Market, 2021-2035.”

The report features an extensive study of the current landscape, offering an informed opinion on the likely adoption of CD47…

Roots Analysis has announced the addition of “Biopreservation Media Providers Market, 2021-2035” report to its list of offerings.

The report features an extensive study of the current market landscape and future potential of the players engaged in offering biopreservation media. The study presents an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain. Amongst other elements, the report features:

 A detailed assessment of the current…

Roots Analysis has announced the addition of “Porphyria Targeting Therapies Market, 2021-2030” report to its list of offerings.

Porphyria is a rare disorder that is characterized by excessive accumulation of porphyrin, a compound that aids in the formation of heme (an essential part of hemoglobin that helps carry oxygen in blood). Any anomaly caused by genetic or acquired abnormalities in heme biosynthesis (produced majorly in bone marrow and liver) can result in toxicity. It is worth…

Given the multifaceted advantages of antibody discovery services and platforms, the field has witnessed an increase in the number of players involved in the development of such solutions. The domain features the presence of over 80 service providers and 124 platform providers which are involved in providing services for antibody discovery. The market is characterized by the presence of small companies / start-ups (up to 50 employees) followed by mid-sized companies (51-500 employees) and…

According to experts in this field, fragment-based drug discovery solutions have facilitated the identification of viable pharmacological leads against otherwise hard to target biomolecules. In fact, many service provider companies are offering fragment libraries and support to the medical research community in order to develop an appropriate intervention to treat the illness caused by the SARS-CoV-2 virus.

To order this 170+ page report, which features 55+ figures and 80+ tables,…